News | November 15, 2006

Breakthrough Algorithms Predict Sudden Cardiac Death Risk

Breakthrough Algorithms Predict Sudden Cardiac Death Risk

AHA in Chicago: GE Healthcare announced this week that it is the only company with two patented algorithms that meet new MN guidelines that help physicians predict whether a patient is at risk for sudden cardiac death (SCD).

“It is GE’s hope that the wealth of detailed, accurate cardiac information provided by these algorithms will help physicians better understand which patients are at highest risk for SCD and enable them to prescribe proactive treatments that can help reduce these deaths,” said Dr. Matthias Weber, vice president of GE Healthcare’s Diagnostic Cardiology business.

When inputted with ambulatory (Holter) electrocardiography (ECG) data, GE’s patented, breakthrough algorithms — Marquette Modified Moving Average (MMA) T-Wave Alternans algorithm and the Marquette Heart Rate Turbulence algorithm –have been shown to help predict if a person is at risk for SCD. A cardiac stress test, when conducted with GE’s CASE stress test system and CardioSoft software, uses the MMA T-Wave Alternans algorithm to evaluate a patient’s risk of SCD.

GE’s Heart Rate Turbulence algorithm measures and compares the heart rate before and after premature beats, providing comparison data used to measure how the patient’s heart and autonomic nervous system work together, which can determine cardiac health.

“Used together, these algorithms interpret complex cardiac rhythms that provide a more accurate, advanced way to determine which patients are at risk for SCD and would benefit most from a implantable defibrillator,” said Dr. Richard L. Verrier, associate professor of Medicine, Harvard Medical School and Beth Israel Deaconess Medical Center. “This noninvasive and portable method for diagnosing patients should significantly benefit those patients who may be at higher risk for SCD or help in prescribing the most appropriate therapies to prevent SCD.”

For more information visit

Related Content

HeartSciences MyoVista ECG Device Shows Promise in Detecting Abnormal Cardiac Function
News | ECG | April 27, 2018
HeartSciences announced the results of a clinical study of its electrocardiography device that applies continuous...
ECG Study of NBA Players Shows Need for Sport-Specific Normative Data and Guidelines
News | ECG | December 08, 2017
Cardiologists at NewYork-Presbyterian/Columbia University Irving Medical Center compared electrocardiographic findings...
HeartSciences Announces CE Mark and European Launch of MyoVista High Sensitivity ECG

Just as a Doppler radar color image shows the energy of a storm, MyoVista provides physicians a detailed visual image of the energy distribution during the cardiac cycle.

News | ECG | August 22, 2017
HeartSciences announced the European launch of the MyoVista high sensitivity electrocardiograph (hsECG) Testing Device...
AUM Cardiovascular Receives FDA Approval for CADence ECG Device
Technology | ECG | August 08, 2017
AUM Cardiovascular announced it has received clearance from the U.S. Food and Drug Administration (FDA) for CADence, a...
More Than 20 Percent of Low-Risk Patients Receive Annual ECG
News | ECG | July 20, 2017
July 20, 2017 — More than one in five Ontario patients receive an ...
Heart Test Laboratories, HTL, MyoVista ECG, common stock offering
News | ECG | January 31, 2017
Heart Test Laboratories Inc. (HTL) has successfully raised $12 million by way of a Common Stock private placement...
AirStrip One, ECG management, web client, U.S. clearance
Technology | ECG | October 11, 2016
The U.S. Food and Drug Administration (FDA) has issued 510(K) Class II clearance to a web client for the AirStrip One...
Carestream, Vue Motion universal viewer, ECG waveforms, diagnostic reading, FDA clearance

Image courtesy of Carestream Health

Technology | ECG | November 20, 2015
Carestream has obtained U.S. Food and Drug Administration (FDA) clearance for diagnostic reading of electrocardiogram (...
CardioSecur mobile ECG, 22-lead, 360 degree view of the heart, CardioSecur Pro

Image courtesy of CardioSecur

Technology | ECG | October 08, 2015
Personal MedSystems introduced the first and only 22-lead mobile electrocardiogram (ECG) system, CardioSecur, at the...
Mortara, ELI 280, TouchScreen ECG, ECG advances, new ECG technology

The Mortara Eli 280 is part of a new generation of ECG systems that integrate touchscreen monitors to improve workflow.

Feature | ECG | September 16, 2015 | Dave Fornell
The resting electrocardiogram (ECG) has been us
Overlay Init